(Reuters) -Bayer said on Tuesday it was preparing market ... to market to treat a condition that results in heart failure. In "late summer" this year, it was eyeing the launch of menopause relief ...

Bayer’s AskBio gene therapy unit has started recruiting patients into a phase 2 trial of its AB-1002 candidate for congestive heart failure (CHF), buoyed by encouraging data from a first-in ...

Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of at least $1 billion, as it seeks to strengthen its pharmaceuticals business ...

Bayer Eyes Launch of Menopause Relief, Heart Drugs This Year (Reuters) -Bayer said on Tuesday it was preparing market launches this year of two new drugs that could each have annual peak sales of ...